tiprankstipranks
Trending News
More News >
Merck & Company (MRK)
NYSE:MRK

Compare Merck & Company (MRK) vs. Competitors

Compare
14,680 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Merck & Company
$108.18
$268.51B
14.31
11.95%
11 Buy
6 Hold
0 Sell
Moderate Buy
AstraZeneca
$92.95
$287.70B
30.63
35.50%
5 Buy
0 Hold
0 Sell
Strong Buy
Gilead Sciences
$135.93
$168.65B
21.05
46.29%
16 Buy
3 Hold
0 Sell
Strong Buy
Novartis
$147.14
$283.14B
19.93
47.10%
1 Buy
4 Hold
1 Sell
Hold
Pfizer
$25.65
$145.84B
14.95
-2.99%
5 Buy
12 Hold
0 Sell
Moderate Buy
Sanofi
$47.20
$113.92B
11.74
-9.20%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MRK
Merck & Company
108.18
13.79
14.61%
AZN
AstraZeneca
92.95
24.31
35.41%
GILD
Gilead Sciences
135.93
43.17
46.54%
NVS
Novartis
147.14
46.77
46.60%
PFE
Pfizer
25.65
0.61
2.43%
SNY
Sanofi
47.20
-4.49
-8.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts